1.
Arshad HME, Ali F, Babar A, Raza MZ, Maqsood M, Ameer A. Survival impact and safety comparison of pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A meta-analysis. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2025 Sep. 30 [cited 2025 Dec. 7];42(3):16432. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/16432